(NASDAQ: TELA) Tela Bio's forecast annual revenue growth rate of 17.58% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.13%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.12%.
Tela Bio's revenue in 2025 is $75,323,000.On average, 1 Wall Street analysts forecast TELA's revenue for 2025 to be $3,383,243,976, with the lowest TELA revenue forecast at $3,383,243,976, and the highest TELA revenue forecast at $3,383,243,976. On average, 1 Wall Street analysts forecast TELA's revenue for 2026 to be $4,195,380,996, with the lowest TELA revenue forecast at $4,195,380,996, and the highest TELA revenue forecast at $4,195,380,996.
In 2027, TELA is forecast to generate $4,797,550,884 in revenue, with the lowest revenue forecast at $4,797,550,884 and the highest revenue forecast at $4,797,550,884.